Effectiveness of Photodynamic Therapy in Elimination of HPV-16 and HPV-18 Associated with CIN I in Mexican Women

Photochem Photobiol. 2017 Oct;93(5):1269-1275. doi: 10.1111/php.12769. Epub 2017 Jul 21.

Abstract

This study aimed to determine the effectiveness of photodynamic therapy (PDT), using δ-aminolevulinic acid (5-ALA), in the elimination of premalignant cervical lesions in Mexican patients with human papillomavirus (HPV) infection and/or cervical intraepithelial neoplasia (CIN). Thirty women diagnosed with CIN I and/or positive for HPV participated in the study. Topical 6% 5-ALA in gel form was applied to the uterine cervix; after 4 h, the lesion area was irradiated with a light dose of 200 J cm-2 at 635 nm. This procedure was performed three times at 48-h intervals. Clinical follow-up was performed at 3, 6, and 12 months after the initial PDT administration, by colposcopy, cervical cytology, histopathological analysis, polymerase chain reaction, and hybrid capture. Of HPV-infected patients without evidence of CIN I, 80% cleared the infection, while HPV associated with CIN I was eliminated in 83% of patients (P < 0.05). At 12 months, CIN I had regressed in 57% of patients, although this response was not statistically significant. PDT using 6% 5-ALA is concluded to be effective in eliminating HPV infection associated or not with CIN I.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aminolevulinic Acid / pharmacology
  • Aminolevulinic Acid / therapeutic use*
  • Female
  • Human papillomavirus 16 / drug effects*
  • Human papillomavirus 18 / drug effects*
  • Humans
  • Mexico
  • Papillomavirus Infections / drug therapy*
  • Papillomavirus Infections / virology*
  • Photochemotherapy / adverse effects*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use*
  • Treatment Outcome
  • Uterine Cervical Dysplasia / drug therapy*
  • Uterine Cervical Dysplasia / virology

Substances

  • Photosensitizing Agents
  • Aminolevulinic Acid